Delivery Order SPE2DB20D3101-SPE2DB23FRNB9
- Not listed
- This federal contract award is for the delivery of ATOMOXETINE HCL 40 MG CAPSULE 30S to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract has a ceiling value of $1,854.72 and is a Firm Fixed Price Delivery Order. The funding agency is the Defense Logistics Agency (DLA), a defense agency that serves as a critical supplier of medical and...
- This federal contract award, valued at $1,720.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4560748911 ATOMOXETINE HCL 60 MG CAPSULE 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the Ultimate Completion Date is April 28, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides delivery orders for the supply of ATOMOXETINE HCL 40 MG CAPSULE 30S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,282.76 and a completion date of September 26, 2024. It is a Firm Fixed Price, Delivery Order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ATOMOXETINE HCL 40 MG CAPSULE 30S, with a potential value of $1,264.71 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp, operating out of its Corporate Office division in...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,532.06, is for the delivery of 4567694566 ATOMOXETINE HCL 25 MG CAPSULE 30S. The contract has a firm fixed price and an ultimate completion date of March 26, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,723.67 award is for the delivery of ATOMOXETINE HCL 40 MG CAPSULE 30S, a pharmaceutical product, with a completion date of February 12, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,391.63, is for the delivery of ATOMOXETINE HCL 40 MG CAPSULE 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of July 15, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This is a federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,000.45, is a Delivery Order for the supply of 4562879322 ! ATOMOXETINE HCL 60 MG CAPSULE 30S. The contract has a period of performance through November 22, 2023 and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp is a for-profit corporate entity that specializes in distributing a...
- This federal contract award, valued at $1,035.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4564675659 ! ATOMOXETINE HCL 40 MG CAPSULE 30S, a prescription medication. This is a Firm Fixed Price Delivery Order contract with a completion date of May 22, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award is a delivery order with a firm fixed price of $1,210.99 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ATOMOXETINE HCL 80 MG CAPSULE 30S to the Defense Logistics Agency, a defense agency. The contract has a period of performance through June 5, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRNB9Delivery Order
This federal contract award is for the delivery of ATOMOXETINE HCL 25 MG CAPSULE 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $2,300.34 and a completion date of June 2, 2023. The award was made on June 1, 2023 and there was no set-aside designation used. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 6/1/23 |